Loading...
Tositumomab and Iodine I 131 Tositumomab (Bexaar)
Tositumomab and iodine I 131 tositumomab (Bexaar) therapeutic regimen targets monoclonal antibodies against the CD20 antigen expressed in non-Hodgkin lymphoma. This article reviews the mechanism of action and clinical indications for this regimen.
Na minha lista:
| Udgivet i: | AJNR Am J Neuroradiol |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society of Neuroradiology
2011
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7965875/ https://ncbi.nlm.nih.gov/pubmed/21436340 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3174/ajnr.A2593 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|